UPDATE 2-European shares rise on COVID-19 drug hopes, upbeat outlook from corporates

* Analysts expect STOXX EPS to decline 40% in Q2 - Refinitiv (Updates price to close)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.